Enhancing the Efficacy and Safety of Doxorubicin against Hepatocellular Carcinoma through a Modular Assembly Approach: The Combination of Polymeric Prodrug Design, Nanoparticle Encapsulation, and Cancer Cell-Specific Drug Targeting-Reference-Cited by-同舟云学术

Enhancing the Efficacy and Safety of Doxorubicin against Hepatocellular Carcinoma through a Modular Assembly Approach: The Combination of Polymeric Prodrug Design, Nanoparticle Encapsulation, and Cancer Cell-Specific Drug Targeting

Published:2018-01-22 Issue:4 Volume:10 Page:3229-3240
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Xu Li¹^ORCID,Xu Shengjun¹,Wang Hangxiang¹^ORCID,Zhang Jun¹,Chen Zun¹,Pan Linhui¹,Wang Jianguo¹,Wei Xuyong¹,Xie Haiyang¹,Zhou Lin¹,Zheng Shusen¹,Xu Xiao¹

Affiliation:

1. Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases; Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, School of Medicine, Zhejiang University, Hangzhou 310003, P. R. China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Zhejiang Province

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.7b14496

Reference48 articles.

1. Global cancer statistics, 2012

2. Emerging trends in hepatocellular carcinoma incidence and mortality